Damora Therapeutics (DMRA) Operating Leases (2019 - 2025)
Damora Therapeutics (DMRA) posted Operating Leases of $53000.0 for Q4 2025, down 7.02% on a QoQ basis from $57000.0 in Q3 2025, and down 13.11% year-over-year from $61000.0 in Q4 2024.
Damora Therapeutics (DMRA) Operating Leases (2019 - 2025) Analysis & Trends
Damora Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $53000.0 for Q4 2025.
- Quarterly Operating Leases fell 13.11% year-over-year to $53000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $53000.0 (down 13.11% YoY) and the FY2025 annual result came in at $53000.0, down 13.11% from the prior year.
- Operating Leases was $53000.0 for Q4 2025 at Damora Therapeutics, down from $57000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $635000.0 in Q2 2021 and bottomed at $53000.0 in Q4 2025.
- A 5-year average of $266000.0 and a median of $234000.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases plunged 79.88% — and 2024, when it retreated 7.58%.
- Damora Therapeutics' Operating Leases stood at $448000.0 in 2021, then retreated by 26.79% to $328000.0 in 2022, then plunged by 79.88% to $66000.0 in 2023, then fell by 7.58% to $61000.0 in 2024, then slipped by 13.11% to $53000.0 in 2025.
- Business Quant data shows DMRA's Operating Leases at $53000.0 in Q4 2025, $57000.0 in Q3 2025, and $60000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | 206,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 440,000.00 |
| Jun 30, 2022 | 305,000.00 |
| Mar 31, 2022 | 402,000.00 |
| Dec 31, 2021 | 448,000.00 |
| Sep 30, 2021 | 511,000.00 |
| Jun 30, 2021 | 635,000.00 |
| Mar 31, 2021 | 544,000.00 |
| Dec 31, 2020 | 541,000.00 |
| Sep 30, 2020 | 589,000.00 |
| Dec 31, 2019 | 211,000.00 |